Bristol Eyes 2008 NDA For DPP-4 Inhibitor Saxagliptin

 
• By Jonathan M. Block

Firm also brokers licensing agreement with Otsuka for the diabetes candidate in Japan.

More from Archive

More from Pink Sheet